GlassScriptPhysician profile
Kelsie C Hoffman
NPI 1548098536
$643.64
in general payments reported to CMS, 2019-2025
12 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $152 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $128.01 | 2025 | Provenge |
| Teleflex LLC | $89.03 | 2024-2025 | Barrigel, Urolift |
| Sumitomo Pharma America, INC. | $84.87 | 2024-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $63.27 | 2025 | Erleada |
| Becton, Dickinson and Company | $56.86 | 2024 | Lutonix Drug Coated Balloon, Fluency Endovascular Stent Graft |
| Vertex Pharmaceuticals Incorporated | $49.38 | 2025 | |
| Urogen Pharma, INC. | $43.91 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $34.78 | 2025 | |
| Merck Sharp & Dohme LLC | $33.51 | 2024-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Calyxo, INC. | $26.32 | 2025 | Cvac Aspiration System |
| Alnylam Pharmaceuticals INC. | $17.47 | 2025 | Givlaari |
| Telix Pharmaceuticals | $16.23 | 2025 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsie Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.